Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ARHGEF7 antisense RNA 1 (ARHGEF7-AS1) is a presumed long non-coding RNA gene transcribed from the antisense strand adjacent to the ARHGEF7 gene, which encodes a Rho guanine nucleotide exchange factor involved in regulation of cytoskeleton, cell migration, and multiple signaling pathways. There are currently no widely recognized biological or pharmacological roles, disease associations, or established molecular functions for ARHGEF7-AS1 itself in the literature. Most research focuses on the ARHGEF7 protein-coding gene, not the antisense RNA. Important distinction: - If your interest is in the established therapeutic signaling target, the correct entity is Rho guanine nucleotide exchange factor 7 (ARHGEF7, β-PIX), not ARHGEF7-AS1. All robust biological/pathological roles and drug research involve ARHGEF7, not ARHGEF7-AS1. - No evidence was identified that ARHGEF7-AS1 acts directly as a drug target, biomarker, or functional regulator at this time. If you intended to query the protein-coding ARHGEF7 gene, please clarify for detailed information relevant to drug targeting, molecular classification, biological function, and disease roles.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ARHGEF7 antisense RNA 1 (ARHGEF7-AS1).